CORONARY HEART-DISEASE RISK-FACTORS IN MORBIDLY OBESE WOMEN WITH NORMAL GLUCOSE-TOLERANCE

被引:25
作者
BARAKAT, HA
MOONEY, N
OBRIEN, K
LONG, S
KHAZANI, PG
PORIES, W
CARO, JF
机构
[1] E CAROLINA UNIV, SCH MED, DEPT MED, GREENVILLE, NC 27834 USA
[2] E CAROLINA UNIV, SCH MED, DEPT BIOSTAT & EPIDEMIOL, GREENVILLE, NC 27834 USA
[3] E CAROLINA UNIV, SCH MED, DEPT SURG, GREENVILLE, NC 27834 USA
关键词
D O I
10.2337/diacare.16.1.144
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To examine if the risk for CHD increases progressively with increases in the BMI of normoglycemic, hyperinsulinemic, morbidly obese women (BMI greater-than-or-equal-to 35 kg/m2). RESEARCH DESIGN AND METHODS - Insulin sensitivity was evaluated by calculating an ISI following an OGTT. There was a significant linear relationship between ISI and BMI fitted by two straight lines intersecting at a point corresponding to a BMI of 29.7 +/- 1.5 kg/m2. Significant linear relationships between insulin sensitivity and BMI were obtained below and above this breakpoint. Similarly, a breakpoint for the relation between dBP and BMI corresponding to a BMI greater-than-or-equal-to 33.7 +/- 3.4 kg/m2 was obtained. Significant linear relationships between BMI and plasma fasting glucose, triglyceride, cholesterol, HDL cholesterol, sBP, or dBP were not observed in the women with a BMI >35 kg/m2. RESULTS - Compared with lean (BMI <27) women of similar age, the morbidly obese patients appear to be at a higher risk for CHD. This is suggested by statistically significant increases in fasting insulin (mean +/- SD; 187 +/- 137 vs. 64.2 +/- 16.2 pM) and triglyceride levels (128 +/- 78.1 vs. 73 +/- 25 mg/dl), sBP (132 +/- 114 vs. 104 +/- 15.8) and dBP (84 +/- 72 vs. 67 +/- 2.1 mmHg), and decreases in HDL cholesterol (1.03 +/- 0.44 vs. 1.29 +/- 0.82 mM) and apo A-1 (91 +/- 55 vs. 122 +/- 35 mg/dl) concentrations. CONCLUSIONS - It appears that there may be a threshold of body mass up to which insulin sensitivity is associated with CHD risk. Above this threshold, there does not appear to be a progressive increase in the risk factors for CHD with increases in BMI.
引用
收藏
页码:144 / 149
页数:6
相关论文
共 30 条
[1]   QUANTITATION OF APOLIPOPROTEIN A-I OF HUMAN-PLASMA HIGH-DENSITY LIPOPROTEIN [J].
ALBERS, JJ ;
WAHL, PW ;
CABANA, VG ;
HAZZARD, WR ;
HOOVER, JJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1976, 25 (06) :633-644
[2]  
BARAKAT HA, 1988, INT J OBESITY, V12, P473
[3]   RISK-FACTORS FOR ISCHEMIC VASCULAR DEATH FOR MEN IN THE STOCKHOLM PROSPECTIVE-STUDY [J].
BOTTIGER, LE ;
CARLSON, LA .
ATHEROSCLEROSIS, 1980, 36 (03) :389-408
[4]   IMPACT OF OBESITY ON INSULIN ACTION IN VOLUNTEERS WITH NORMAL GLUCOSE-TOLERANCE - DEMONSTRATION OF A THRESHOLD FOR THE ADVERSE EFFECT OF OBESITY [J].
CAMPBELL, PJ ;
GERICH, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (04) :1114-1118
[5]   CELLULAR ALTERATIONS IN LIVER, SKELETAL-MUSCLE, AND ADIPOSE-TISSUE RESPONSIBLE FOR INSULIN RESISTANCE IN OBESITY AND TYPE-II DIABETES [J].
CARO, JF ;
DOHM, LG ;
PORIES, WJ ;
SINHA, MK .
DIABETES-METABOLISM REVIEWS, 1989, 5 (08) :665-689
[7]   THE MECHANISM OF ALLOXAN PROTECTION IN EXPERIMENTAL ATHEROSCLEROSIS [J].
COOK, DL ;
MILLS, LM ;
GREEN, DM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1954, 99 (02) :119-124
[8]   RELATIONSHIP OF PLASMA-INSULIN LEVELS TO THE INCIDENCE OF MYOCARDIAL-INFARCTION AND CORONARY HEART-DISEASE MORTALITY IN A MIDDLE-AGED POPULATION [J].
DUCIMETIERE, P ;
ESCHWEGE, E ;
PAPOZ, L ;
RICHARD, JL ;
CLAUDE, JR ;
ROSSELIN, G .
DIABETOLOGIA, 1980, 19 (03) :205-210
[9]   THE EFFECT OF ALLOXAN DIABETES ON EXPERIMENTAL CHOLESTEROL ATHEROSCLEROSIS IN THE RABBIT .4. THE EFFECT OF INSULIN THERAPY ON THE INHIBITION OF ATHEROSCLEROSIS IN THE ALLOXAN-DIABETIC RABBIT [J].
DUFF, GL ;
BRECHIN, DJH ;
FINKELSTEIN, WE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1954, 100 (04) :371-380
[10]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499